लोड हो रहा है...
Phase II study of VEGF trap for the treatment of metastatic thyroid cancer
BACKGROUND: Several multi-targeted tyrosine kinase inhibitors (TKIs) have activity in RAI-refractory thyroid cancer. The anti-tumor effect is attributed at least in part to their ability to inhibit angiogenesis in these vascular tumors. VEGF Trap (VT) is a recombinantly-produced fusion protein consi...
में बचाया:
| में प्रकाशित: | Cancer |
|---|---|
| मुख्य लेखकों: | , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6773269/ https://ncbi.nlm.nih.gov/pubmed/31174237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32046 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|